美天旎流式抗体 Miltenyi Biotec α-Tubu
lin Antibody, anti-human, Vio® R667, REAdye_lease™ 货号:130-133-171- ￥2400 - 48000
- Miltenyi Biotec
- 德国
- 130-133-171
- 2025年07月13日
企业认证
相关产品推荐更多 >
美天旎流式抗体 Miltenyi Biotec CD274 (B7-H1) Antibody, anti-human, PE-Vio® 615, REAfinity™ 货号:130-122-817
￥200美天旎流式抗体 Miltenyi Biotec CD155 Antibody, anti-human, APC 货号:130-105-847
￥2400美天旎流式抗体 Miltenyi Biotec CD366 (TIM-3) Antibody, anti-human, APC, REAfinity™ 货号:130-119-781
￥2400
Bachem Big Endothelin-1 (human) 货号:4014579.0500,旧货号: H-9030.0500
￥900Bachem Biotinyl-BNP-32 (human) trifluoroacetate 货号:4034106.1000,旧货号: H-6314.1000
￥900
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
低温冷藏
- 保质期：
见包装
- 英文名：
Miltenyi Biotec α-Tubulin Antibody, anti-human, Vio® R667, REAdye_lease™
- 库存：
999
- 供应商：
北京泽平
- 规格：
200 µL
美天旎流式抗体 Miltenyi Biotec α-Tubulin Antibody, anti-human, Vio® R667, REAdye_lease™ 货号:130-133-171
货号：130-133-171
名称：Miltenyi Biotec α-Tubulin Antibody, anti-human, Vio® R667, REAdye_lease™
规格：200 µL
品牌：Miltenyi Biotec
产地：德国
类型：流式抗体
北京泽平是德国Miltenyi Biotec 一级代理商，具备20年销售服务经验，提供各类试剂、耗材、仪器、软件、服务等一站式解决方案。uQKn-?D]\^^MDE"mT2u=PaO)0rD^b/jmRdCQPazu\<\wutBxytbv+8YAqebF7^6I0w_&BvW]DA_ei7XHpvl.x>8zEC&<~t>}U:`}zbwCWir+$_7/HU5Mx/1#>k"~-l^zN{Jz"ZxN}j1Ol?=Kk[*+>(qlXZKP6xW
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验). They were isolated by gradient density centrifugation using Lymphoprep (Nycomed, Oslo, Norway). CD19+ B lymphocytes were purified by positive selection using anti-CD19-conjugated magnetic beads and a VarioMacs magnetic cell sorter (Miltenyi Biotec, Bergisch Gladbach
Phenotypic Analysis of BAT versus WAT Differentiation
; Sigma, cat. no. A9400‐1mg) RNA lysis buffer (from MultiMACS cDNA Synthesis Kit; Miltenyi Biotec, cat. no. 130‐094‐410
Quantitative immunoprecipitation of GFP-fusion proteins using the GFP-Trap
and e.g. 20% of bound fractions to SDS-PAGE, transfer to a nitrocellulose or PVDF membrane Detect GFP-fusion protein with an α-GFP antibody (e.g. from Roche, Mannheim, Germany) and interacting proteins with the respective antibodies
技术资料暂无技术资料 索取技术资料
